EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer
1 other identifier
interventional
40
1 country
1
Brief Summary
This trial examines the role of EUS-FNA (Oesophageal Endoscopic Ultrasound with Fine Needle Aspiration) as an endoscopic technique for the mediastinal staging of patients with lung cancer. Patients will be randomized to either conventional surgical technique or EUS-FNA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 lung-cancer
Started Feb 2005
Shorter than P25 for phase_2 lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 1, 2005
CompletedFirst Posted
Study publicly available on registry
July 13, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2007
CompletedDecember 28, 2007
December 1, 2007
July 1, 2005
December 19, 2007
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of surgical interventions avoided
Secondary Outcomes (1)
Accuracy of EUS-FNA for mediastinal staging of lung cancer
Interventions
Eligibility Criteria
You may qualify if:
- patients with histological or cytological proof of non small cell lung cancer (NSCLC) or with a high clinical suspicion for lung cancer (but without pathologically confirmed diagnosis from the bronchoscopy or CT guided transthoracal biopsies) in whom the next step is normally a diagnostic or therapeutic surgical intervention
- no distant metastases after routine clinical work up (PET is optional, not mandatory)
- provision of a written informed consent
- recent CT-scan of the thorax (\<28 days before randomization date)
- age 18 years or older
- clinically fit for surgery
You may not qualify if:
- proof of small cell lung cancer (SCLC) with CWU (bronchoscopy or CT guided transthoracal punction)
- stage IV NSCLC
- patients with a solitary pulmonary nodule (thus without enlarged mediastinal lymph nodes on CT and without mediastinal PET hot spots) : these do not require further mediastinal investigation
- former therapy (chemotherapy or radiotherapy or surgery) for lung cancer
- other concomitant malignancies
- reasons for which the patient is unable to swallow the EUS-instrument (e.g. zenker diverticulum, unexplained esophageal stenosis)
- uncorrected coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Ghent
Ghent, 9000, Belgium
Related Publications (1)
Tournoy KG, De Ryck F, Vanwalleghem LR, Vermassen F, Praet M, Aerts JG, Van Maele G, van Meerbeeck JP. Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial. Am J Respir Crit Care Med. 2008 Mar 1;177(5):531-5. doi: 10.1164/rccm.200708-1241OC. Epub 2007 Oct 25.
PMID: 17962631DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kurt Tournoy, MD
University Hospital, Ghent
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 1, 2005
First Posted
July 13, 2005
Study Start
February 1, 2005
Study Completion
February 1, 2007
Last Updated
December 28, 2007
Record last verified: 2007-12